Compare Flowserve Corporation Common Stock (FLS) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flowserve Corporation Common Stock vs Immunovant Inc. Common Stock — how do they compare? Flowserve Corporation Common Stock trades at $71.41 (market cap $8.85B), while Immunovant Inc. Common Stock trades at $30.56 (market cap $6.25B). The key difference: Flowserve Corporation Common Stock is the larger of the two by market cap, and Flowserve Corporation Common Stock pays a 1.26% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FLS | IMVT | |
|---|---|---|
Market Cap | $8.85B | $6.25B |
Volume | 1,955,324 | 1,755,411 |
Sector | Industrials | Health |
52-Week High | $92.04 | $44.96 |
52-Week Low | $49.09 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.44B | $5.35B |
Dividend Yield | 1.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Flowserve Corporation Common Stock
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
